LogicFlo AI, an AI platform based in Boston, has secured $2.7 million in seed funding led by Lightspeed, with contributions from healthcare and enterprise AI investors.
The investment will drive LogicFlo AI's global growth within pharmaceutical, biotech, and medtech organizations, enabling more extensive deployment with a Fortune 500 company already on board.
LogicFlo AI replaces disjointed tools in regulated scientific work with intelligent AI agents supervised by humans, empowering professionals in various fields to execute high-compliance workflows faster and accurately.
The company plans to speed up product development, enhance integrations with life sciences systems, and expand its teams to address industry demand, aiming to transform scientific work execution on a broader scale.